Western blotting analysis using dihydropyrimidine dehydrogenase antibody (Cat#61151). Total cell lysates (30 μg) from various cell lines were loaded and separated by SDS-PAGE. The blot was incubated with dihydropyrimidine dehydrogenase antibody (Cat#61151, 1:5,000) and HRP-conjugated goat anti-rabbit secondary antibody (Cat#201, 1:20,000) respectively. Image was developed using NaQ™ ECL Substrate Kit (Cat#716).
Western blotting analysis using Dihydropyrimidine dehydrogenase antibody (Cat#61151). Dihydropyrimidine dehydrogenase expression in wild type (WT) and Dihydropyrimidine dehydrogenase shRNA knockdown (KD) HeLa cells with 20 μg of total cell lysates. β-Tubulin serves as a loading control. The blot was incubated with Dihydropyrimidine dehydrogenase antibody (Cat#61151, 1:5,000) and HRP-conjugated goat anti-rabbit secondary antibody (Cat#201, 1:20,000) respectively. Image was developed using NaQ™ ECL Substrate Kit (Cat#716).
Flow cytometric analysis of dihydropyrimidine dehydrogenase expression in H9c2 cells using dihydropyrimidine dehydrogenase antibody (Cat#61151, 1:2,000). Green, isotype control; red, dihydropyrimidine dehydrogenase.
Immunocytochemical staining of H9C2 cells with dihydropyrimidine dehydrogenase antibody (Cat#61151, 1:1,000). Nuclei were stained blue with DAPI; Dihydropyrimidine dehydrogenase was stained magenta with Alexa Fluor® 647. Images were taken using Leica stellaris 5. Protein abundance based on laser Intensity and smart gain: Medium. Scale bar, 20 μm.
Immunohistochemistry was performed on paraffin-embedded human hepatocarcinoma using dihydropyrimidine dehydrogenase antibody (Cat#61151, 1:200). Antigen retrieval was done in sodium citrate buffer (pH 6.0). DAB was used for detection, with hematoxylin counterstaining. Images were acquired using a Nikon Ci-L Plus microscope (40× objective). Scale bar, 25 μm.
